These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 189271

  • 1. [Antibodies against the Epstein-Barr Virus nuclear-antigen in children with malignant disease (author's transl)].
    Lubec G, Jürgenssen O.
    Osterr Z Onkol; 1976; 3(4):96-9. PubMed ID: 189271
    [Abstract] [Full Text] [Related]

  • 2. [Antibodies against the Epstein-Barr virus, capsid antigen in children with malignant neoplasms (author's transl)].
    Lubec G, Krepler P.
    Padiatr Padol; 1976; 11(1):88-93. PubMed ID: 175342
    [Abstract] [Full Text] [Related]

  • 3. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
    Kuljić-Kapulica N.
    Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
    [Abstract] [Full Text] [Related]

  • 4. Humoral antibodies to the capsid antigen of Epstein-Barr virus in Hodgkin's disease.
    Stepina VN, Gourtsevicz VE, Mazurenko NP, Yarymova NM, Kaverznyeva MM, Lorye YI.
    Neoplasma; 1976; 23(5):523-32. PubMed ID: 185535
    [Abstract] [Full Text] [Related]

  • 5. Epstein-Barr virus (EBV) antibodies in children with non-Hodgkin's lymphomas.
    Roubalová K, Weinreb M, Roubal J, Kodet R, Koutecký J, Vonka V.
    Acta Virol; 1988 Jul; 32(4):339-48. PubMed ID: 2903639
    [Abstract] [Full Text] [Related]

  • 6. [Levels of Epstein-Barr virus antibodies in the serum of children with acute lymphoblastic leukemia].
    Holý J, Hrodek O, Hynieová H, Petrtýlová K, Srajer J, Vanĕcek K.
    Cesk Pediatr; 1981 May; 36(5):248-53. PubMed ID: 6266677
    [No Abstract] [Full Text] [Related]

  • 7. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
    Berkel AI, Henle W, Henle G, Ersoy F, Sanal O, Klein G, Yeğin O.
    Kroc Found Ser; 1985 May; 19():287-300. PubMed ID: 2999343
    [Abstract] [Full Text] [Related]

  • 8. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
    Mitarnun W, Pradutkanchana J, Takao S, Saechan V, Suwiwat S, Ishida T.
    J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
    [Abstract] [Full Text] [Related]

  • 9. [Epstein-Barr virus and infectious mononucleosis. A clinical study of Epstein-Barr antibodies (author's transl)].
    Seigneurin JM, Kressmann MC, Lavoué MF, Saez G, Lenoir G.
    Nouv Presse Med; 1978 Dec 09; 7(44):4005-10. PubMed ID: 215969
    [Abstract] [Full Text] [Related]

  • 10. Invited discussion: relationship of titers of Epstein-Barr virus to cell-mediated immunity in patients with Hodgkin's disease.
    Levine PH, Reisher JI.
    Natl Cancer Inst Monogr; 1973 May 09; 36():85-7. PubMed ID: 4355354
    [No Abstract] [Full Text] [Related]

  • 11. Antibody against synthetic peptide derived from Epstein-Barr virus-determined nuclear antigen 1 (EBNA-1) in child non-Hodgkin's lymphoma.
    Sova P, Roubalová K, Weinreb M, Hamsíková E, Kodet R, Krchnák V, Roubal J.
    Acta Virol; 1990 Apr 09; 34(2):132-8. PubMed ID: 1975974
    [Abstract] [Full Text] [Related]

  • 12. Correlation between mixed lymphocyte cultures and anti-Epstein Barr virus (EBV) antibodies in Hodgkin's disease and non Hodgkin lymphoma patients.
    Sasiain MC, Fejes M, Ares BR, Brezavscek D, Bachmann AE.
    Biomedicine; 1981 Oct 09; 35(5):153-6. PubMed ID: 6274439
    [Abstract] [Full Text] [Related]

  • 13. Cells containing Epstein--Barr nuclear antigen (EBNA) in peripheral blood.
    Gergely L, Czeglédy J, Váczi L, Szalka A, Berényi E.
    Acta Microbiol Acad Sci Hung; 1979 Oct 09; 26(1):41-5. PubMed ID: 225932
    [Abstract] [Full Text] [Related]

  • 14. Cell-mediated immune reactions in three patients with malignant lymphoproliferative diseases in remission and abnormally high Epstein-Barr virus antibody titers.
    Masucci MG, Szigeti R, Ernberg I, Björkholm M, Mellstedt H, Henle G, Henle W, Pearson G, Masucci G, Svedmyr E, Johansson B, Klein G.
    Cancer Res; 1981 Nov 09; 41(11 Pt 1):4292-301. PubMed ID: 6272973
    [Abstract] [Full Text] [Related]

  • 15. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G, Mellstedt H, Masucci MG, Szigeti R, Ernberg I, Björkholm M, Tsukuda K, Henle G, Henle W, Pearson G.
    Cancer Res; 1984 Mar 09; 44(3):1288-300. PubMed ID: 6318984
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus-related serology in Hodgkin's disease.
    Henle W, Henle G.
    Natl Cancer Inst Monogr; 1973 May 09; 36():79-84. PubMed ID: 4355353
    [No Abstract] [Full Text] [Related]

  • 17. The Epstein-Barr virus (EBV) in human pathology. Results of a serological investigation of a hospital population.
    Dalens M, Didier J, Pris J, Enjalbert L.
    Biomedicine; 1973 Jul 09; 18(4):336-45. PubMed ID: 4139980
    [No Abstract] [Full Text] [Related]

  • 18. Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies.
    Lindahl T, Klein G, Reedman BM, Johansson B, Singh S.
    Int J Cancer; 1974 Jun 15; 13(6):764-72. PubMed ID: 4137165
    [No Abstract] [Full Text] [Related]

  • 19. [Malignant lymphoma which contained EBV DNA and lacked EBNA2 antibody].
    Shimakage M, Hirai K, Ikegami N, Matsubuchi T, Kawagoe H.
    Rinsho Ketsueki; 1989 Jul 15; 30(7):1091-2. PubMed ID: 2554014
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.